Exhibit 107
Calculation of Filing Fee Table
Form F-1
(Form Type)
Psyence Biomedical Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| ||||||||||||
| Security | Security | Fee | Amount | Proposed | Maximum | Fee Rate | Amount of | Carry | Carry | Carry | Filing Fee Previously Paid In Connection with |
Fees to be Paid | Equity | Common Shares | 457(c) | 10,400,000(2) | $0.111(3) | $1,154,400 | 0.00015310 | $176.74 | — | — | — | — |
| Equity | Common Shares Issuable Upon Exercise of Warrants | 457(g) | 500,000 | $0.50(5) | $250,000 | 0.00015310 | $38.28 | — | — | — | — |
Fees Previously Paid | — | — | — | — | — | — | — | — | — | — | — | — |
Carry Forward Securities | ||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | — |
| | | | | Total Offering Amounts | $1,404,400 | | $215.02 | | | | |
| | | | | Total Fees Previously Paid | | | | | | | |
| | | | | Total Fee Offsets | | | — | | | | |
| | | | | Net Fee Due | | | $215.02 | | | | |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), an indeterminable number of additional securities are also being registered to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(2) | Represents up to an aggregate of 10,400,000 common shares, no par value (the “Common Shares”) of Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (the “Company”), issuable pursuant to those certain Second Tranche Notes (as defined in the Registration Statement on Form F-1) issued to certain investors by the Company on June 14, 2024, |
(3) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common stock on the Nasdaq Global Market on September 27, 2024, in accordance with Rule 457(c) of the Securities Act. |
(4) | Calculated pursuant to Rule 457 of the Securities Act by multiplying the proposed maximum aggregate offering price of securities to be registered by 0.00015310. |
(5) | Pursuant to Rule 457(g) of the Securities Act and solely for the purpose of calculating the registration fee, the proposed maximum aggregate offering price of such Common Shares underlying warrants is calculated based on the exercise price of $0.50 per Common Share. |
